Johanniskraut Sidroga

Hypericum perforatum, the active ingredient in Johanniskraut Sidroga, is a herbal extract presented as an oral preparation for oral use. It is traditionally employed to support mild to moderate mood disturbances and seasonal affective symptoms in adult patients. It is available as a standardized extract containing hypericin and hyperforin, the constituents thought to contribute to its activity.

GNH USA supplies Johanniskraut Sidroga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support international distribution.

Johanniskraut Sidroga is used primarily for mood‑related conditions and related affective disorders. Clinical observations suggest benefit in several affective and stress‑related conditions. - Mild to moderate depression: may help improve mood and alleviate depressive symptoms. - Seasonal affective disorder: supports mood stabilization during seasonal changes. - Minor anxiety: may reduce feelings of nervousness and improve emotional well‑being. - Sleep disturbances: may aid in improving sleep quality associated with mood disorders. - Stress‑related fatigue: may help alleviate fatigue linked to chronic stress.

Adverse reactions to Johanniskraut Sidroga are reported with varying frequency and severity.

Common Side Effects: - Photosensitivity: increased sensitivity to sunlight, leading to sunburn‑like reactions. - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Dizziness: transient light‑headedness or balance disturbances. - Fatigue: feeling unusually tired or weak.

Serious or Rare Side Effects: - Serotonin syndrome: potentially life‑threatening condition with agitation, hyperthermia, and muscle rigidity. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Liver enzyme elevation: abnormal liver function tests indicating possible hepatic stress.

When considering Johanniskraut Sidroga, several safety measures and warnings should be observed. - Pregnancy: safety not established; avoid unless prescribed by a qualified healthcare professional. - Breastfeeding: insufficient data; discuss risks with a medical provider before use. - Photosensitivity: limit sun exposure and use protective clothing or sunscreen. - Drug interactions: review all concomitant medications, especially serotonergic agents, before initiating therapy. - Medical conditions: use with caution in patients with bipolar disorder or a history of mania. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Johanniskraut Sidroga can affect the pharmacokinetics or pharmacodynamics of several medicines; awareness of these interactions is essential.

Major Interactions (Avoid): - SSRIs (e.g., sertraline, fluoxetine): combined use may precipitate serotonin syndrome. - MAO inhibitors: concurrent administration can lead to hypertensive crises and serotonin excess. - Oral contraceptives: hypericum may lower plasma concentrations, reducing contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Warfarin: hypericum can enhance anticoagulant effect; monitor INR closely. - Cyclosporine: may decrease cyclosporine levels; therapeutic drug monitoring is recommended.